Kevin Starkweather
Adult Health · Springfield, ILNPI 1275189565
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Abbott at 45.9% of the total. 2025 is the largest year on record at $125, 2.5 times the $51 reported in 2023. That places this record below the midpoint for adult health clinicians in IL, where the typical reported total is $288.
Across 14 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$123
- AbbVie$80
- Medtronic$30
- Xeris Pharmaceuticals, Inc.$19
- Corcept Therapeutics$16
What the payments were for
- Food & beverage$269100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 6 | $123 |
| AbbVie | 5 | $80 |
| Medtronic | 1 | $30 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $16 |
How this compares
$269 in reported general payments places this provider in the 45th percentile of 553 adult health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 313 | $434,181 |
| MounjaroTirzepatide | 213 | $255,058 |
| JardianceEmpagliflozin | 156 | $236,112 |
| TrulicityDulaglutide | 105 | $136,990 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $97,653 |
| Humalog Kwikpen U-200Insulin Lispro | 14 | $83,262 |
| Teriparatide | 12 | $75,118 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 56 | $74,142 |
| Tresiba Flextouch U-100Insulin Degludec | 91 | $72,924 |
| RybelsusSemaglutide | 49 | $69,192 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 105 | $52,770 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 40 | $51,895 |
| Tresiba Flextouch U-200Insulin Degludec | 39 | $48,051 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 287 | $42,701 |
| FarxigaDapagliflozin Propanediol | 22 | $35,256 |
Paid to pharmacies, not to this prescriber.
Other adult health in Springfield
- Nancy ChathamSpringfield$5K
- Brittney VeenstraSpringfield$3K
- Kimberly KearnsHoffman Estates$531K
- Leslie ForresterArlington Heights$97K
- Colleen FolkersChicago$86K
- Matthew BurkeChicago$44K
- Jacklyn GideonChicago$38K
- Jennifer GreenfieldChicago$35K
- Tammy PomaChicago$32K
- Tammy BrownNorth Chicago$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.